ID
32072
Description
Study ID: 103992 Clinical Study ID: 103992 Study Title: Evaluate immunogenicity, reactogenicity & safety of 2 doses of GSK Biologicals’ oral live attenuated HRV vaccine (RIX4414 at 106.5 CCID50) when given concomitantly with OPV versus given alone (HRV vaccine dose given 15 days after the OPV dose) in healthy infants in Bangladesh Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00139334 https://clinicaltrials.gov/ct2/show/NCT00139334?term=NCT00139334&rank=1 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Rotavirus Vaccine Trade Name: Rotarix Study Indication: Haemophilus influenzae type b; Neisseria Meningitidis This form contains the trial's Eligibility Criteria. To be filled in at visit 1, prior to any study procedures. Timing: Day 0 Age: 6 weeks +/- 1 day
Lien
https://clinicaltrials.gov/ct2/show/NCT00139334?term=NCT00139334&rank=1
Mots-clés
Versions (2)
- 16/10/2018 16/10/2018 - Sarah Riepenhausen
- 16/10/2018 16/10/2018 - Sarah Riepenhausen
Détendeur de droits
GlaxoSmithKline
Téléchargé le
16 octobre 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
GSK Biologicals' oral HRV vaccine given with OPV in infants NCT00139334
Eligibility Criteria
- StudyEvent: ODM
Description
Eligibility Check
Alias
- UMLS CUI-1
- C0013893
Description
Inclusion criteria
Alias
- UMLS CUI-1
- C1512693
Description
Subjects who the investigator believes that their parents/guardians can and will comply with the requirements of the protocol (e.g., completion of the diary cards, return for follow-up visits) should be enrolled in the study. (1)
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C1321605
- UMLS CUI [1,2]
- C0030551
Description
A male or female between, and including, 6 weeks +/- 1 week of age at the tiem of Visit 1. (2)
Type de données
boolean
Alias
- UMLS CUI [1]
- C0001779
Description
Written informed consent obtained from the parent or guardian of the subject. (3)
Type de données
boolean
Alias
- UMLS CUI [1]
- C0021430
Description
Free of obvious health problems as established by medical history and clinical examination before entering into the study. (4)
Type de données
boolean
Alias
- UMLS CUI [1]
- C1446390
Description
Exclusion Criteria
Alias
- UMLS CUI-1
- C0680251
Description
Use of any investigational or non-registered product (drug or vaccine) other than the study vaccine(s) within 30 days preceding the first dose of study vaccine, or planned use during the study period. (5)
Type de données
boolean
Alias
- UMLS CUI [1]
- C0013230
Description
Planned administration of a vaccine not foreseen by the study protocol within 14 days before each dose of study vaccine(s) and ending 14 days after. (6)
Type de données
boolean
Alias
- UMLS CUI [1]
- C0042196
Description
Chronic administration (defined as more than 14 days) of major immunosuppressants (equivalent to prednisone 1mg/kg/day) since birth. (Topical steroids are allowed.) (7)
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0021081
- UMLS CUI [1,2]
- C2347852
Description
Malnutrition (< 3Z score weight for age). (8)
Type de données
boolean
Alias
- UMLS CUI [1]
- C0162429
Description
History of/or intercurrent polio disease. (9)
Type de données
boolean
Alias
- UMLS CUI [1]
- C0032371
Description
Previous confirmed occurrence of RV GE. (10)
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0017160
- UMLS CUI [1,2]
- C0035870
Description
History of use of experimental RV vaccine. (11)
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C0597418
Description
Previous routine vaccination except BCG, HBV and OPV vaccination at birth (should be documented in the CRF). (12)
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0042196
- UMLS CUI [1,2]
- C0679831
Description
Any clinically significant history of chronic gastrointestinal disease including any uncorrected congenital malformation of the gastrointestinal tract, intussusception or other medical condition determined to be serious by the investigator. (13)
Type de données
boolean
Alias
- UMLS CUI [1]
- C0017178
- UMLS CUI [2,1]
- C4023588
- UMLS CUI [2,2]
- C4072785
- UMLS CUI [3,1]
- C3843040
- UMLS CUI [3,2]
- C0205404
Description
Any confirmed or suspected immunosuppressive or immunodeficient condition, including human immunodeficiency virus (HIV) infection. (14)
Type de données
boolean
Alias
- UMLS CUI [1]
- C3829792
- UMLS CUI [2]
- C4048329
- UMLS CUI [3]
- C0019693
Description
History of allergic disease or reaction likely to be exacerbated by any component of the vaccine. (15)
Type de données
boolean
Alias
- UMLS CUI [1]
- C2106654
Description
Acute disease at the time of enrolment. (Acute disease is defined as the presence of a moderate or severe illness with or without fever. All vaccines can be administered to persons with a minor illness such as mild upper respiratory infection with or without low- grade febrile illness, i.e. Oral temperature <37.5°C (99.5°F) / Axillary temperature <37.5°C (99.5°F) / Rectal temperature <38°C (100.4°F).) (16)
Type de données
boolean
Alias
- UMLS CUI [1]
- C0001314
Description
A family history of congenital or hereditary immunodeficiency. (17)
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0241889
- UMLS CUI [1,2]
- C0853602
- UMLS CUI [2,1]
- C0241889
- UMLS CUI [2,2]
- C0439660
- UMLS CUI [2,3]
- C0021051
Description
Administration of immunoglobulins and/or blood products since birth or planned administration during the study period. (18)
Type de données
boolean
Alias
- UMLS CUI [1]
- C0021027
- UMLS CUI [2]
- C0456388
Description
History of any neurologic disorders or seizures. (19)
Type de données
boolean
Alias
- UMLS CUI [1]
- C0027765
- UMLS CUI [2]
- C0036572
Description
Acute or chronic, clinically significant pulmonary, cardiovascular, hepatic or renal functional abnormality, as determined by physical examination or laboratory screening tests. (20)
Type de données
boolean
Alias
- UMLS CUI [1]
- C0231921
- UMLS CUI [2]
- C0678859
- UMLS CUI [3]
- C0232804
- UMLS CUI [4]
- C0232741
Similar models
Eligibility Criteria
- StudyEvent: ODM
C0030551 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,2])
C0035870 (UMLS CUI [1,2])
C0597418 (UMLS CUI [1,2])
C0679831 (UMLS CUI [1,2])
C4023588 (UMLS CUI [2,1])
C4072785 (UMLS CUI [2,2])
C3843040 (UMLS CUI [3,1])
C0205404 (UMLS CUI [3,2])
C4048329 (UMLS CUI [2])
C0019693 (UMLS CUI [3])
C0853602 (UMLS CUI [1,2])
C0241889 (UMLS CUI [2,1])
C0439660 (UMLS CUI [2,2])
C0021051 (UMLS CUI [2,3])
C0456388 (UMLS CUI [2])
C0036572 (UMLS CUI [2])
C0678859 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
C0232741 (UMLS CUI [4])